Glycoengineering CAR-T cells to overcome galectin-3-mediated immunosuppression.

Front Immunol · 2026 · PMC12956802 · PMID 41789075

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although Gal-1, Gal-3, and Gal-9 transcripts trended higher in early-failure patients, these differences did not reach statistical significance ( Supplementary Figure 1b-d ), suggesting that galectin expression alone may not stratify clinical outcomes.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.